Publication | Closed Access

Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer

Androgen ReceptorBreast OncologyMedicineImmunologyAdjuvant ChemotherapyBreast CancerCell BiologyCytokeratin 5/6OncologyRadiation OncologyTumor BiologyEndocrine-related Cancer